argenx stock heads to Boston and London investor conferences
Published on 11/04/2026 at 17:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSNovember conferences set investor focus
- argenx management is scheduled for fireside chats in Boston on November 10 and London on November 17.
- Live webcasts and replays of the appearances are expected through the investor section.
argenx announced on November 3 that members of its management team will join two healthcare investor conferences this month, according to Ideal Investisseur. The appearances put scheduled management access, rather than a new earnings release, at the center of the near-term investor calendar.
Two management appearances scheduled
The first event is the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston. argenx management is scheduled for a fireside chat on Tuesday, November 10, at 2:00 p.m. Eastern Time.
The second appearance is planned for the Jefferies London Global Healthcare Conference on Tuesday, November 17, at 8:30 a.m. Greenwich Mean Time. The events give investors two opportunities to hear management discuss the immunology business and development portfolio.
The announcement did not attach new financial guidance or clinical results to either appearance. That leaves the conference dates and access to management as the immediate company-specific checkpoints.
Webcasts provide the next checkpoints
Live presentations will be available through the investor section of the argenx website, with replays expected to remain accessible for approximately 30 days after each presentation.
argenx stock traded at 812.60 euros on Lang & Schwarz at 17:38 CET on Wednesday, November 4, 2026. Investors can follow the real-time quote of argenx stock.
argenx SE stock facts
- Company: argenx SE
- ISIN: NL0010832176
- Ticker: ARGX
- Lang & Schwarz quote: 812.60 euros at 17:38 CET on Wednesday, November 4, 2026
The Dutch market backdrop is covered in current AEX market reports.
